Harris claims that 20 years ago, the ‘Federal Drug Administration’ approved mifepristone.
Kamala Harris, the current vice president, said last week that the “Federal Drug Administration” had given its blessing to the abortion drug mifepristone 20 years ago. It turned out that she was incorrect.
Although the Federal Drug Administration (FDA) might appear like a more natural approach to split apart the term, the Food and Drug Administration (FDA) is the correct body.
On Friday night, Harris gave an interview to Vanessa Hauc of Noticias Telemundo. Harris discussed abortion and the current political climate in the United States in this interview.
Allow me to set the scene.Many months ago, the United States Supreme Court removed a constitutional right that had been acknowledged by the people and women of America, Harris said. “The right to make decisions about your own body and reproductive health was a right that had been recognized by the people and women of America,” Harris added. The government has no business telling a woman how to treat her own body. This makes me think of certain fundamental liberties, such as the freedom to choose one’s own path in life.
The vice president then discussed mifepristone, an abortion medication approved by the Food and Drug Administration in 2000.
The FDA’s clearance of the medicine was challenged in court by pro-life doctors and medical organisations. The dispute here is not over the effectiveness of the tablet itself, but rather the FDA’s judgment in approving it almost two decades ago.
When the FDA authorized mifepristone 20 years ago, Harris explained, “politicians found a court, a specific court they thought would help them,” to remove it from sale.
She then ordered everyone to have a look at any prescription medications they might have.
Harris stated that all medications administered had been approved by the FDA, regardless of whether they alleviated pain or improved quality of life.
Her words: “It could be argued that what they are doing with mifepristone could happen to any of the medicines in your medicine cabinet.”
On the same day that the interview with Harris was published, the Supreme Court ruled that women can continue to have unrestricted access to the abortion pill while the issue is heard in lower federal courts.
Because a judge Trump appointed, Matthew J. Kacsmaryk, sided with pro-life groups and blocked the FDA from approving mifepristone, the case made it all the way to the Supreme Court.
Kacsmaryk’s ruling was partially reversed by the 5th U.S. Circuit Court of Appeals, although the appeals court maintained restrictions limiting distribution to no more than seven weeks and prohibiting postal delivery.
The Justice Department has warned that maintaining the drug’s current restrictions might lead to anarchy.
A federal court in Washington, D.C. has added further complexity by ordering the FDA to continue allowing mifepristone to be sold under the present regulations. This was in response to a second lawsuit brought by 17 states led by Democrats plus DC.
The two-drug combination of mifepristone and misoprostol is used to induce labor and expel a fetus that has already stopped developing and is no longer receiving the hormones it needs to survive.
The medicine has a 97% success rate for terminating an early pregnancy, but the manufacturer reports that 3% of women who take it will require surgery because the pregnancy is continuing, they are bleeding heavily, or they did not get all of the baby out.